Similares a Atacicept Approval Brings BAFF/APRIL Targeting to IgAN With Richard Lafayette, MD

20 vecinos (text_768) · 173 views · HCPLive · Estados Unidos


★	Atacicept Approval Brings BAFF/APRIL Targeting to IgAN With Richard Lafayette, MD	HCPLive @hcplivenews	173	Estados Unidos
16	Phase 3 VISIONARY: Sibeprenlimab May Preserve #KidneyFunction in IgA Nephropathy	HCPLive @hcplivenews	981	Estados Unidos	83
3	Nefropatía por IgA en adultos Una revisión actualizada	ENSEÑANDO MEDICINA INTERNA @carloswaldomi	690	—	85
14	One Year of Brensocatib: How Bronchiectasis Care Has Changed	HCPLive @hcplivenews	399	Estados Unidos	83
15	SGLT2 EN ERC Beneficio en todos los estadios	ENSEÑANDO MEDICINA INTERNA @carloswaldomi	383	—	83
13	TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity	HCPLive @hcplivenews	350	Estados Unidos	83
4	Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy	HCPLive @hcplivenews	233	Estados Unidos	85
2	Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy	HCPLive @hcplivenews	199	Estados Unidos	85
9	Functional Cures for T1D: Insulin Independence Through Islet Transplantation	HCPLive @hcplivenews	185	Estados Unidos	83
19	Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3	HCPLive @hcplivenews	158	Estados Unidos	83
10	Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes	HCPLive @hcplivenews	143	Estados Unidos	83
5	Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies	HCPLive @hcplivenews	109	Estados Unidos	84
7	Volixibat Improves Itch, Fatigue in PSC, Supporting “Patient-Centered” Care	HCPLive @hcplivenews	59	Estados Unidos	84
20	Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More \| EAC 2026	HCPLive @hcplivenews	58	Estados Unidos	83
8	Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD	HCPLive @hcplivenews	55	Estados Unidos	83
6	Why Does IgA Nephropathy Affect More Men? With Ramy Hanna, MD	HCPLive @hcplivenews	52	Estados Unidos	84
1	B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD	HCPLive @hcplivenews	27	Estados Unidos	89
11	The Pathologist’s Role in IgAN Management	ReachMD @reachmd	6	Estados Unidos	83
12	The Pathologist’s Role in IgAN Management	ReachMD @reachmd	6	Estados Unidos	83
17	Seeking Expert Opinions in IgAN Care	ReachMD @reachmd	6	Estados Unidos	83
18	Seeking Expert Opinions in IgAN Care	ReachMD @reachmd	3	Estados Unidos	83